Canopy Growth Corporation
Canopy Growth Corporation (CGC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cgc · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Canopy Growth Corporation (CGC) measures how much investors pay for each dollar of the company's trailing earnings. CGC's current PE ratio of N/A is calculated by dividing its stock price of $1.02 by its TTM earnings per share of -$0.95.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2010 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Canopy Growth CorporationYou CGC | $434M | N/A | — | -$0.95 |
 Aurora Cannabis Inc. ACB | $202M | 217.84x | +81.1% | $0.03 |
 Aclaris Therapeutics, Inc. ACRS | $526M | N/A | — | -$0.53 |
 BioAge Labs, Inc. BIOA | $584M | N/A | — | -$2.24 |
 Cabaletta Bio, Inc. CABA | $522M | N/A | — | -$1.64 |
 Definitive Healthcare Corp. DH | $89M | N/A | — | -$1.30 |
 Ironwood Pharmaceuticals, Inc. IRWD | $542M | 22.76x | -81.1% | $0.15 |
Industry Average 2 peers with valid PE | — | 120.30x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-5.56 | — | |
2024-03-31 FY2024 | — | $-6.47 | — | |
2023-03-31 FY2023 | — | $-70.69 | — | |
2022-03-31 FY2022 | — | $-7.92 | — | |
2021-03-31 FY2021 | — | $-4.65 | — | |
2020-03-31 FY2020 | — | $-3.77 | — | |
2019-03-31 FY2019 | — | $-2.18 | — | |
2018-03-31 FY2018 | — | $-0.38 | — | |
2017-03-31 FY2017 | — | $-0.06 | — | |
2016-03-31 FY2016 | — | $-0.05 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Canopy Growth Corporation (CGC) measures how much investors pay for each dollar of the company's trailing earnings. CGC's current PE ratio of N/A is calculated by dividing its stock price of $1.02 by its TTM earnings per share of -$0.95.
Frequently asked questions
CGC pe ratio · 6 questionsCGC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.02 and TTM EPS of -$0.95. Data sourced from Financial Modeling Prep via CGC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Canopy Growth Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08